@maijinggene.com
Maijing Gene is a gene detection technology company that specializes in R&D, production, and sales of molecular diagnostic products.
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
About
Description
Maijing Gene, also known as Mygene, is a leading biotechnology company specializing in the development, production, promotion, and sales of molecular diagnostic products. Established in 2015, Maijing Gene is headquartered in Guangzhou National Biotechnology Island, with branches in East China, Central China, and North China. They also have a cutting-edge research and development center in Silicon Valley, USA.
Maijing Gene is dedicated to driving the application of next-generation high-throughput sequencing technology in precision medicine. They have obtained national certifications and operate a third-party medical testing institute in Guangzhou. With a focus on precision medicine, Maijing Gene has built a comprehensive medical system that integrates production, education, research, and medical services.
Their main technology platforms include qPCR, Sanger sequencing, and NGS. By collaborating with top scientists and clinical experts in the fields of molecular biology, genetic information, genetics, and pathology, Maijing Gene strives to provide accurate, convenient, and comprehensive services to patients, physicians, and healthcare institutions. Their goal is to become a trusted provider of precision medicine solutions.
Development milestones for Maijing Gene include establishing the team in August 2015 and moving to Guangzhou National Biotechnology Island in November of the same year. They signed a strategic partnership agreement with ThermoFisher, one of the world's top 500 companies, in November 2015. In April 2016, they established a joint laboratory with the First Affiliated Hospital of Zhongshan University.
Maijing Gene obtained medical institution qualification for medical testing in February 2017. In April 2017, they set up a research and development center in Silicon Valley, USA, and received national certification as a high-tech enterprise. In April 2018, Maijing Gene secured a multimillion-dollar Series A funding from Shenzhen Capital Group.
And in May 2018, they established a GMP production site in the Huangpu district of Guangzhou. With a commitment to precision medicine and an impressive development history, Maijing Gene is at the forefront of revolutionizing the field of molecular diagnostics
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories